Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taperSCIENCE TRANSLATIONAL MEDICINEIF14.62022-06-2241PRE
Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare HealthJOURNAL OF SUBSTANCE ABUSE TREATMENTIF42021-07-0139OAAI
The association of prefrontal cortex response during a natural reward cue-reactivity paradigm, anhedonia, and demoralization in persons maintained on methadoneADDICTIVE BEHAVIORSIF3.62021-02-0117OAAI
Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing IndividualsJOURNAL OF ADDICTION MEDICINEIF3.22020-01-016OAAI
Perceived Attitudes About Substance Use in Anonymous Social Media Posts Near College Campuses: Observational StudyJMIR MENTAL HEALTHIF5.82018-08-025OAAI
Enhancing Patient Navigation with Contingent Incentives to Improve Healthcare Behaviors and Viral Load Suppression of Persons with HIV and Substance UseAIDS PATIENT CARE AND STDSIF3.82018-07-0115OA
Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE studyclinical psychology science and practiceIF3.22017-06-2723OAAI
N-Aryl Piperazine Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators Possess Efficacy in Preclinical Models of NMDA Hypofunction and Cognitive EnhancementJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82013-11-0146OAAI
Discovery of a Novel Chemical Class of mGlu5 Allosteric Ligands with Distinct Modes of PharmacologyACS CHEMICAL NEUROSCIENCEIF3.92010-08-1970OAAI
Synthesis, SAR and Unanticipated Pharmacological Profiles of Analogues of the mGluR5 Ago-potentiator ADX-47273CHEMMEDCHEMIF3.42009-04-0939OAAI